Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Cyclo Therapeutics Inc logo

Cyclo Therapeutics Inc

Sector: Professional, Scientific, and Technical Services   

Industry: Research and Development in Biotechnology

1.39
 
USD
  
-0.01
  
(-0.71%)
Optionable: No  Market Cap: 40 M  90-day average vol: 95,864

Previous close: 1.4  Open: 1.38  Bid: 1.35  Ask: 1.5
52 week range    
0.67   
   2.57
Peers   
Last updated: Friday 29th March 2024
27
MarketXLS Rank
40
Value
15
Technical
28
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

CYTH Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-5.6-2.24-1.83
Basic EPS total-5.6-2.24-1.83
Basic weighted shares outstanding37 M51 M56 M63 M72 M82 M1 M2 M6 M8 M
Cost of sales-426022.0-272641.0-124425.0-198429.0-132918.0126640.0102938.0-78592.0-185124.0-163008.0
Depreciation148041.0152446.0169030.0107096.09271.010124.05681.012763.016827.019481.0
Depreciation unreconciled148041.0152446.0169030.0107096.09271.010124.05681.012763.016827.019481.0
DepreciationAndAmortization148041.0152446.0169030.0107096.09271.010124.05681.012763.016827.019481.0
DevelopmentExpense136128.0
Diluted EPS total0.01-0.01-0.05-0.07-0.05-0.05-6.97-5.6-2.24-1.83
Diluted normalized net income/share-6.97
Diluted weighted shares outstanding20 M59 M51 M60 M77 M85 M1 M2 M6 M8 M
Fees-109473.0
GainOnSaleOfPPE2000.0700.0-48668.02817.0
GainOnSaleOfSecurity2129.03300.06670.010649.010261.011773.012027.019802.0
GeneralAndAdministrativeExpense275309.0775284.0789167.01 M1 M1 M1 M607797.02 M3 M
Gross operating profit1 M1 M768476.01 M-156765.0-126640.0-212411.0981968.02 M2 M
ImpairmentOfCapitalAssets-400000.0
Income before tax284909.0-592687.0-2 M-4 M-4 M-4 M-7 M-9 M-14 M-15 M
Income taxes80000.0-16000.0120000.0-153000.0-139000.0-185000.0-265000.0
InsuranceAndClaims117555.0
InterestExpenseNonOperating53865.033673.031290.028603.095431.0
MarketingExpense526480.0
MiscOtherSpecialCharges1 M1 M1 M19802.0-3405.0170998.0
Net income from total operations204909.0-592687.0-3 M-4 M-4 M-4 M-7 M-9 M-14 M-15 M
NetIncomeCommonStockholders204909.0-592687.0-3 M-4 M-4 M-4 M-7 M-9 M-14 M-15 M
NetIncomeContinuousOperations204909.0-592687.0-3 M-4 M-4 M-4 M-7 M-9 M-14 M-15 M
NetNonOperatingInterestIncomeExpense-53865.0-33673.0-31290.0-28603.0-95431.0
Normalized income-11 M-12 M
Operating income430100.0-562314.0-2 M-3 M-5 M-5 M-8 M-9 M-14 M-16 M
Operating income before depreciation (EBITDA)486815.0-406568.0-2 M-4 M-4 M-4 M-7 M-9 M-14 M-15 M
OperatingExpense-1 M-2 M-3 M5 M5 M5 M8 M10 M16 M17 M
Other income net91326.0-3300.0117630.0848019.0-1 M-1 M-1 M-19802.03405.0-170998.0
OtherGandA275309.0775284.0789167.01 M1 M1 M1 M607797.02 M3 M
OtherImpairmentOfCapitalAssets95455.0125000.0810000.0
OtherOperatingExpenses110744.0526480.095431.017006.017636.016166.0
Research & development expense94133.0658505.02 M2 M3 M5 M6 M9 M9 M
ResearchExpense94133.0658505.02 M2 M3 M5 M6 M9 M9 M
Revenue per share109473.0
SalariesAndWages364227.0648531.0907744.01 M1 M1 M2 M3 M4 M4 M
SecuritiesAmortization109473.0
Selling Gen & administrative expense275309.0775284.01 M1 M1 M1 M1 M1 M3 M4 M
SellingAndMarketingExpense526480.0136128.0507474.01 M1 M
SellingExpense136128.0
Special income/charges400000.0-117555.0
Total Income available for interest expense (EBIT)338774.0-559014.0-2 M-4 M-4 M-4 M-7 M-9 M-14 M-15 M
Total common shares outstanding49 M55 M59 M73 M74 M91 M122 M6 M8 M11 M
Total net income204909.0-592687.0-3 M-4 M-4 M-4 M-7 M-9 M-14 M-15 M
Total ordinary shares23 M23 M23 M23 M23 M23 M23 M23 M23 M23 M
Total revenues2 M2 M950455.02 M1 M1 M-109473.0903376.02 M1 M
TotalExpenses-2 M-2 M-3 M4 M5 M5 M8 M10 M16 M17 M
TotalRevenue2 M2 M950455.02 M1 M1 M-109473.0903376.02 M1 M
WriteOff117555.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University